Authors/Disclosures
|
Neekita Jikaria
|
No disclosure on file |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Ramon R. Diaz-Arrastia, MD, PhD, FAAN
(University of Pennsylvania)
|
Dr. Diaz-Arrastia has stock in BrainBox, LLC. Dr. Diaz-Arrastia has stock in Nia Therpeutics. The institution of Dr. Diaz-Arrastia has received research support from National Institutes of Health. The institution of Dr. Diaz-Arrastia has received research support from Department of Defense. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Guy A. Rouleau, MD, PhD, FAAN
(Montreal Neurological Institute and Hospital)
|
Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma. |
|
Guy A. Rouleau, MD, PhD, FAAN
(Montreal Neurological Institute and Hospital)
|
Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma. |
|
L. C. Turtzo, MD, PhD
(NIH / NINDS)
|
No disclosure on file |
|
Marcondes C. Franca, Jr., MD
|
Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA. |
|
|
No disclosure on file |